Cargando...
CD73: an emerging checkpoint for cancer immunotherapy
CD73 is a novel immune checkpoint associated with adenosine metabolism that promotes tumor progression by suppressing antitumor immune response and promoting angiogenesis. The inhibition of CD73, in combination with immune checkpoint blockade, targeted therapy or conventional therapy, improves antit...
Gardado en:
| Publicado en: | Immunotherapy |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Future Medicine Ltd
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6609898/ https://ncbi.nlm.nih.gov/pubmed/31223045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt-2018-0200 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|